Force. The finalized document is approved by the CPG for publication in the European Heart
Journal. The Guidelines were developed after careful consideration of the scientific and …

2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A
Report of the American College of Cardiology/American Heart Association Task Force on …

The recommendations listed in this guideline are, whenever possible, evidence-based. An
initial extensive evidence review, which included literature derived from research involving …

The “Guidelines on the Management of Valvular Heart Disease” were initially published as
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …

Pulmonary stenosis (PS) accounts for approximately 8% of all congenital heart defects. 1
Valvular PS is usually an isolated defect, but it can be associated with other congenital heart …

The most common form of right ventricular outflow tract (RVOT) obstruction is pulmonary
valve stenosis. Pulmonary stenosis (PS) occurs in isolation in 8%–10% of congenital heart …

Interventions in adults with congenital heart disease (ACHD) focus on surgical and
percutaneous interventions in light of rapidly evolving ACHD clinical practice. To bring rigour …

The number of patients with congenital heart disease (CHD), particularly those with complex
malformations, is rapidly increasing thanks to recent improvements in surgical outcomes. It …

Heart failure is an increasing reason for hospitalization and the leading cause of death in
patients with adult congenital heart disease (ACHD). Recently, the European Society of …

Congenital heart disease (CHD) is a problem in the structure of the heart that is present at
birth. CHD is still the most common inborn defect with an approximate prevalence at birth of …